- 全部删除
 您的购物车当前为空 您的购物车当前为空
Safotibant (LF-22-0542) 是一种缓激肽 B1 受体拮抗剂,具有抗炎和镇痛活性,可用于局部治疗糖尿病性黄斑水肿。


为众多的药物研发团队赋能,
让新药发现更简单!
Safotibant (LF-22-0542) 是一种缓激肽 B1 受体拮抗剂,具有抗炎和镇痛活性,可用于局部治疗糖尿病性黄斑水肿。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 593 | In stock | |
| 5 mg | ¥ 1,480 | In stock | |
| 10 mg | ¥ 2,220 | In stock | |
| 25 mg | ¥ 3,580 | In stock | |
| 50 mg | ¥ 4,950 | In stock | |
| 100 mg | ¥ 6,530 | In stock | |
| 200 mg | ¥ 8,880 | In stock | 
Safotibant 相关产品
| 产品描述 | Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema. | 
| 体内活性 | LF22-0542 (1% in saline; eye drop; twice a day for 7 days; diabetic rats) significantly reduced Retinal plasma extravasation, leukostasis, and mRNA levels of B(1)R, iNOS, COX-2, VEGF receptor type 2, IL-1β and HIF-1α to the control value level.[1] | 
| 别名 | LF22-0542, LF-22-0542, LF-220542, LF220542, LF 22-0542, LF 220542 | 
| 分子量 | 502.63 | 
| 分子式 | C25H34N4O5S | 
| CAS No. | 633698-99-4 | 
| Smiles | S(N(CCOCC(N(CC1=CC=C(C=C1)C=2NCCN2)C)=O)C)(=O)(=O)C3=C(C)C=C(OC)C=C3C | 
| 密度 | 1.23 g/cm3 (Predicted) | 
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (99.48 mM), Sonication is recommended.   | ||||||||||||||||||||||||||||||
| 溶液配制表 | |||||||||||||||||||||||||||||||
| DMSO 
 | |||||||||||||||||||||||||||||||
 比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,
比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,  一共给药动物 10 只 ,您使用的配方为 5%
 一共给药动物 10 只 ,您使用的配方为 5%  DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。
DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。 
评论内容